摘要 |
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein Ar, X, m, R<SUP>1</SUP>, R<SUP>2 </SUP>are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I for treatment of 5-HT6-mediated diseases.
|